Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Salient Bio is a UK-based private diagnostics and laboratory-services company operating as the trading name of Salient Labs Limited. The company combines microbiome metagenomics, automation, bioinformatics, and machine learning to develop and commercialize non-invasive diagnostic tests, while also running an ISO 17025-accredited laboratory that provides microbiome analysis, blood pathology, stool testing, custom sample kits, and digital reporting tools for healthcare providers and other business customers. Its near-term product focus includes a microbiome-based diagnostic test for inflammatory bowel disease, and the company has also highlighted a strategic interest in women's health applications. In parallel with product development, Salient Bio generates revenue from lab services and white-label/turnkey testing infrastructure for partners in the UK healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Salient Bio.